medigraphic.com
SPANISH

Alergia, Asma e Inmunología Pediátricas

Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 1

<< Back

Alerg Asma Inmunol Pediatr 2016; 25 (1)

Kawasaki shock syndrome. Case report in a 10 month toddler

del Monte MEA, González LRH, García DM, Yamasaki NMA, Huerta LJG
Full text How to cite this article

Language: Spanish
References: 11
Page: 30-33
PDF size: 284.11 Kb.


Key words:

Toxic shock, Kawasaki disease, nursling.

ABSTRACT

Kawasaki disease (KD) is a systemic vasculitis which regularly presents with stable vital signs. Shock rarely occurs in such cases, but it may occur in the acute phase of KD. This report describes a 10-month-old girl with KD shock syndrome (KDSS) who presented with persistent fever, injected conjunctiva, a polymorphic skin rash, echocardiography indicating coronary artery dilatation, and shock. The patient’s haemodynamic status markedly improved with immunoglobulin therapy. Early recognition of KDSS can be challenging; however, delay in diagnosis can increase the risk of coronary artery abnormalities, cardiac failure and death.


REFERENCES

  1. Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110: 2747-2771.

  2. Kanegaye JT, Wilder MS, Molkara D et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009; 123 (5): e783-e789.

  3. Gámez-González LB, Yamazaki-Nakashimada MA. Enfermedad de Kawasaki, ¿una enfermedad exótica y rara? Alerg Asma Inmunol Pediatr. 2012; 21 (1): 23-35.

  4. Nakamura Y, Yashiro M, Uehara R et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. 2012; 22: 216-221.

  5. Yeung RS. Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol. 2010; 22: 551-560.

  6. Chen PS, Chi H, Huang FY, Peng CC, Chen MR, Chiu NC et al. Clinical manifestations of Kawasaki disease shock yndrome: A case-control study. J Microbiol Immunol Infect. 2015; 48: 43-50. 12. Yamazaki-Nakashimada MA, Gámez-González LB. Formas graves de enfermedad de Kawasaki. Enfermedad de Kawasaki. México: Editores de Textos Mexicanos (ETM); 2015: 151-164.

  7. Ralston M, Hazinski MF, Zaritsky AL, Schexnayder SM, Klein-man ME. Pediatric Advanced Life Support Provider Manual. Dallas, TX: American Heart Association; 2006.

  8. Fitzmaurice L, Gerardi MJ. Cardiovascular system. In: Gausche-Hill M, Fuchs S, Yamamoto L, eds. APLS: The Pediatric Emergency Medicine Resource. 4th ed. Sudbury, MA: Jones and Bartlett; 2007, pp. 106-145.

  9. Ralston M, Hazinski MF, Zaritsky AL, Schexnayder SM, Kleinman ME. Pediatric Advanced Life Support Provider Manual. Dallas, TX: American Heart Association; 2006.

  10. Fitzmaurice L, Gerardi MJ. Cardiovascular system. In: Gausche-Hill M, Fuchs S, Yamamoto L, eds. APLS: The Pediatric Emergency Medicine Resource. 4th ed. Sudbury, MA: Jones and Bartlett; 2007, pp. 106-145.

  11. Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glode MP. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics. 2008; 122: e786-e790.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Alerg Asma Inmunol Pediatr. 2016;25